XML 87 R71.htm IDEA: XBRL DOCUMENT v3.6.0.2
Condensed Financial Statements of Parent Company (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Assets [Abstract]        
Cash and cash equivalents $ 36,990 $ 36,990 $ 25,854 $ 36,990
Securities available-for-sale     199,365 214,192
Other assets     15,543 14,418
Total Assets     902,966 896,787
Liabilities & Stockholders' Equity [Abstract]        
Common stock     24,806 24,795
Additional paid-in capital     16,427 16,392
Retained earnings     56,965 55,151
Accumulated other comprehensive loss     (4,208) (3,162)
Total liabilities and stockholders' equity     902,966 896,787
Income: [Abstract]        
Other income 113 133    
Total interest and dividend income 29,826 30,295    
Expenses: [Abstract]        
Salaries and benefits 19,878 20,747    
Legal expenses 1,315 720    
Service fees 807 693    
Other operating expenses 2,355 2,362    
Total noninterest expense 34,831 35,086    
Income before income taxes 3,957 3,688    
Income tax expense 160 54    
Net income 3,797 3,634    
Cash flows from operating activities: [Abstract]        
Net income 3,797 3,634    
Adjustments to reconcile net income to net cash provided by operating activities:        
Increase in other assets (567) (3,969)    
Increase (decrease) in other liabilities (243) 3,637    
Net cash provided by operating activities 8,653 7,833    
Cash flows from investing activities: [Abstract]        
Proceeds from maturity of investment securities 0 300    
Net cash flows from investing activities (23,637) (15,413)    
Cash flows from financing activities: [Abstract]        
Cash dividends paid on common stock (1,983) (1,686)    
Net cash provided by financing activities 3,848 11,265    
Net increase (decrease) in cash and cash equivalents (11,136) 3,685    
Cash and cash equivalents at beginning of period 36,990 33,305    
Cash and cash equivalents at end of period 25,854 36,990    
Supplemental schedule of noncash transactions: [Abstract]        
Unrealized gain (loss) on securities available-for-sale (1,762) (755)    
Parent Company [Member]        
Assets [Abstract]        
Cash and cash equivalents 2,366 2,198 2,366 2,198
Securities available-for-sale     164 99
Investment in common stock of subsidiaries     91,437 90,836
Other assets     31 58
Total Assets     93,998 93,191
Liabilities & Stockholders' Equity [Abstract]        
Note payable - subsidiary     8 15
Common stock     24,806 24,795
Additional paid-in capital     16,427 16,392
Retained earnings     56,965 55,151
Accumulated other comprehensive loss     (4,208) (3,162)
Total liabilities and stockholders' equity     $ 93,998 $ 93,191
Income: [Abstract]        
Dividends from subsidiary 2,900 2,900    
Other income 200 200    
Total interest and dividend income 3,100 3,100    
Expenses: [Abstract]        
Salaries and benefits 406 432    
Legal expenses 774 180    
Service fees 166 137    
Other operating expenses 55 19    
Total noninterest expense 1,401 768    
Income before income taxes 1,699 2,332    
Income tax expense (408) (193)    
Net income before equity in undistributed net income of subsidiaries 2,107 2,525    
Equity in undistributed net income of subsidiaries 1,690 1,109    
Net income 3,797 3,634    
Cash flows from operating activities: [Abstract]        
Net income 3,797 3,634    
Adjustments to reconcile net income to net cash provided by operating activities:        
Equity in undistributed net income of subsidiaries (1,690) (1,109)    
Increase in other assets 5 (5)    
Increase (decrease) in other liabilities (7) 15    
Net cash provided by operating activities 2,105 2,535    
Cash flows from investing activities: [Abstract]        
Net cash flows from investing activities 0 0    
Cash flows from financing activities: [Abstract]        
Proceeds from sale of stock 46 0    
Cash dividends paid on common stock (1,983) (1,686)    
Net cash provided by financing activities (1,937) (1,686)    
Net increase (decrease) in cash and cash equivalents 168 849    
Cash and cash equivalents at beginning of period 2,198 1,349    
Cash and cash equivalents at end of period 2,366 2,198    
Supplemental schedule of noncash transactions: [Abstract]        
Unrealized gain (loss) on securities available-for-sale $ 64 $ (1)